| Anticancer boron-containing prodrugs responsive to oxidative stress from the tumor microenvironment H Maslah, C Skarbek, S Pethe, R Labruère European Journal of Medicinal Chemistry 207, 112670, 2020 | 48 | 2020 |
| Prodrugs as drug delivery system in oncology J Delahousse, C Skarbek, A Paci Cancer Chemotherapy and Pharmacology 84, 937-958, 2019 | 31 | 2019 |
| Arylboronate prodrugs of doxorubicin as promising chemotherapy for pancreatic cancer C Skarbek, S Serra, H Maslah, E Rascol, R Labruère Bioorganic chemistry 91, 103158, 2019 | 28 | 2019 |
| Preactivated oxazaphosphorines designed for isophosphoramide mustard delivery as bulk form or nanoassemblies: synthesis and proof of concept C Skarbek, LL Lesueur, H Chapuis, A Deroussent, C Pioche− Durieu, ... Journal of medicinal chemistry 58 (2), 705-717, 2015 | 22 | 2015 |
| In‐Cell Generation of Anticancer Phenanthridine Through Bioorthogonal Cyclization in Antitumor Prodrug Development H Maslah, C Skarbek, C Gourson, MA Plamont, S Pethe, L Jullien, ... Angewandte Chemie International Edition 60 (45), 24043-24047, 2021 | 12 | 2021 |
| Photodegradation of methotrexate in aqueous solution: degradation kinetics and identification of transformation products A Espinosa, S Nélieu, P Lieben, C Skarbek, R Labruère, P Benoit Environmental Science and Pollution Research 29 (4), 6060-6071, 2022 | 7 | 2022 |
| Structural modification and biological activity studies of tagitinin C and its derivatives TH Au, C Skarbek, S Pethe, R Labruere, JP Baltaze, TPH Nguyen, ... Tetrahedron 92, 132248, 2021 | 5 | 2021 |
| Simultaneous quantification of preactivated ifosfamide derivatives and of 4-hydroxyifosfamide by high performance liquid chromatography–tandem mass spectrometry in mouse plasma … A Deroussent, C Skarbek, A Maury, H Chapuis, E Daudigeos-Dubus, ... Journal of Chromatography B 992, 30-35, 2015 | 5 | 2015 |
| Re-designing environmentally persistent pharmaceutical pollutant through programmed inactivation: The case of methotrexate A Espinosa, E Rascol, MA Flos, C Skarbek, P Lieben, E Bannerman, ... Chemosphere 306, 135616, 2022 | 4 | 2022 |
| Poly-isoprenylated ifosfamide analogs: preactivated antitumor agents as free formulation or nanoassemblies C Skarbek, J Delahousse, C Pioche-Durieu, S Baconnais, A Deroussent, ... International journal of pharmaceutics 532 (2), 748-756, 2017 | 4 | 2017 |
| Oxazaphosphorines combined with immune checkpoint blockers: dose-dependent tuning between immune and cytotoxic effects J Delahousse, C Skarbek, M Desbois, JL Perfettini, N Chaput, A Paci Journal for Immunotherapy of Cancer 8 (2), 2020 | 3 | 2020 |
| Enhanced activity of pre-activated oxazaphosphorine prodrugs designed for drug delivery strategy: influence of the length of the engrafted group. C Skarbek, H Chapuis, L Lesueur, M Rivard, T Martens, D Desmaele, ... Cancer Research 73 (8_Supplement), 5671-5671, 2013 | 3 | 2013 |
| Development of a clot-adhesive coating to improve the performance of thrombectomy devices C Skarbek, V Anagnostakou, E Procopio, M Epshtein, CM Raskett, ... Journal of NeuroInterventional Surgery 15 (12), 1207-1211, 2023 | | 2023 |
| Synthesis of 6-methylphenanthridines and evaluation against human papillomavirus-related endocervical adenocarcinoma (KB 3.1) cells H Maslah, C Skarbek, R Labruère Phytochemistry Letters 54, 146-152, 2023 | | 2023 |
| Molecular Imaging of Experimental Abdominal Aortic Aneurysms Targeting Vascular Homeostasis Disruption via CD31 Shedding JN Sénémaud, C Skarbek, J Vigne, F Rouzet, Y Castier, G Caligiuri European Journal of Vascular and Endovascular Surgery 64 (6), 735-736, 2022 | | 2022 |
| Between the Devil and the Deep Blue Sea: New Insights into the Effects of Cancer Therapy on Abdominal Aortic Aneurysm Growth J Sénémaud, C Skarbek European Journal of Vascular and Endovascular Surgery 64 (2), 265, 2022 | | 2022 |
| Derivatives of oxazaphosphorines and therapeutic uses thereof A Paci, T Martens, M Rivard, D Desmaele, C Skarbek, P Couvreur US Patent 10,098,901, 2018 | | 2018 |
| Synthèse et évaluation pharmacologique d’analogues préactivés de l’ifosfamide: prodrogues et nanoparticules à visée antitumorale C Skarbek Université Paris Saclay (COmUE), 2017 | | 2017 |
| Combined strategy based on pre-activated analogs of oxazaphosphorines for increased therapeutic index and immune modulation J Delahousse, C Skarbek, V Gauthier, M Desbois, E Roger, ... Cancer Research 77 (13_Supplement), 2195-2195, 2017 | | 2017 |
| New oxazaphosphorine prodrugs for immunotherapy and nanomedicine against cancer C Skarbek, H Gonde, M Desbois, J Delahousse, N Chaput-Gras, ... Cancer Research 76 (14_Supplement), 2194-2194, 2016 | | 2016 |
